Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SynchroMed II Programmable Drug Infusion System Post-Approval Study

NCT00773019 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT00773019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00773019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SynchroMed II Programmable Drug Infusion System Post-Approval Study
Lead sponsor
MedtronicNeuro
Phase
Observational
Overall status
Completed
Start date
November 30, 2004
Completion date
November 30, 2008
Enrollment
84 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, severe spasticity